Coya Therapeutics Inc (COYA) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Coya Therapeutics Inc (COYA) following the 2026 Q2 hedge fund 13F filings?

As of today, COYA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), COYA gained -18.1% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Coya Therapeutics Inc (COYA)

55 + Investors. Track Smart Money conviction in COYA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — COYA

Based on 55 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their COYA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

🏔️

At the ownership peak (95% of max)

95% of all-time peak

55 hedge funds hold COYA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +112% more funds vs a year ago

fund count last 6Q

+29 new funds entered over the past year (+112% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 57% buying

34 buying26 selling

Last quarter: 34 funds bought or added vs 26 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

⚠️

Fewer new buyers each quarter (-16 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 7 → 7 → 28 → 12. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔄

Mostly new holders — 53% entered in last year

■ 22% conviction (2yr+) ■ 25% medium ■ 53% new

Only 12 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +3%, value -30%

Value

-29%

+3%

Last quarter: funds added +3% more shares while total portfolio value only changed -30%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

5 → 7 → 7 → 28 → 12 new funds/Q

New funds entering each quarter: 7 → 7 → 28 → 12. A growing number of institutions are discovering COYA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 59% of holders entered in last year

■ 21% veterans ■ 20% 1-2yr ■ 59% new

Of 56 current holders: 33 (59%) entered in the past year, only 12 (21%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 10% AUM from top-100

10% from top-100 AUM funds

16 of 55 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

5.6

out of 10

Moderate Exit Risk

Exit risk score 5.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	55	58	-5.17%
13F Shares	8M	8M	3.36%
Total Value	$32M	$46M	-29.85%
New Positions	12	28	-16
Increased Positions	22	19	+3
Closed Positions	15	6	+9
Reduced Positions	10	5	+5
Total Calls	1	0	100%
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

-5.17%

13F Shares

3.36%

Total Value

$32M

$46M

-29.85%

New Positions

-16

Increased Positions

Closed Positions

Reduced Positions

Total Calls

100%

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

55 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COYA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 COYA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	CM Management, LLC	1.49%	400,000	$2.3M
2	DME Capital Management, LP	0.35%	2,335,540	$13.7M
3	AIGH Capital Management LLC	0.23%	631,912	$3.7M
4	Prosight Management, LP	0.17%	170,000	$994K
5	JBF Capital, Inc.	0.08%	100,006	$585K
6	Long Corridor Asset Management Ltd	0.07%	38,766	$227K
7	Private Management Group Inc	0.06%	384,217	$2.2M
8	Prelude Capital Management, LLC	0.04%	101,330	$593K
9	Axq Capital, LP	0.01%	19,809	$116K
10	Alyeska Investment Group, L.P.	0.01%	800,000	$4.7M
11	ADAR1 Capital Management, LLC	0.01%	40,900	$239K
12	GHP Investment Advisors, Inc.	0.01%	26,171	$153K
13	Occudo Quantitative Strategies LP	0.01%	16,823	$98K
14	XTX Topco Ltd	0.00%	41,401	$242K
15	Bfsg, LLC	0.00%	3,455	$20K
16	Renaissance Technologies LLC	0.00%	192,986	$1.1M
17	Quadrature Capital Ltd	0.00%	30,783	$180K
18	Marshall Wace, LLP	0.00%	249,793	$1.5M
19	Oppenheimer & Co Inc	0.00%	18,000	$105K
20	Allworth Financial LP	0.00%	13,000	$76K
21	Jones Financial Companies Lllp	0.00%	110,910	$610K
22	Squarepoint Ops LLC	0.00%	33,260	$195K
23	IFP Advisors, Inc	0.00%	2,000	$12K
24	Cetera Investment Advisers	0.00%	34,000	$199K
25	Vanguard Fiduciary Trust Co	0.00%	129,551	$758K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Coya Therapeutics Inc (COYA)

What does the Smart Money Trend signal show for COYA?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their COYA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for COYA?

Slight buying edge — 57% buying: Last quarter: 34 funds bought or added vs 26 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for COYA holders?

Smaller funds dominant — 10% AUM from top-100: 16 of 55 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held COYA?

Mostly new holders — 53% entered in last year: Only 12 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Coya Therapeutics Inc (COYA) following the 2026 Q2 hedge fund 13F filings?

As of today, COYA has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), COYA has gained -18.1% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Coya Therapeutics Inc (COYA)

Smart Money Signals — COYA

Selling streak — 1 quarter in a row

At the ownership peak (95% of max)

Fast accumulation — +112% more funds vs a year ago

Slight buying edge — 57% buying

Fewer new buyers each quarter (-16 vs last Q)

Mostly new holders — 53% entered in last year

Buying through price weakness — shares +3%, value -30%

Growing discovery — still being found

Early stage — 59% of holders entered in last year

Smaller funds dominant — 10% AUM from top-100

Institutional Sentiment Summary — COYA

Hedge Fund Ownership: COYA

Market Analysis: COYA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: COYA

Is It Too Late to Buy Coya Therapeutics Inc (COYA) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: COYA

Statistics: COYA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Coya Therapeutics Inc (COYA)

Welcome to 13Foresight!